Maintains the corporate record and the governance machinery — entity records, board and committee support, resolutions and minutes, delegations of authority, insurance, and business continuity. Use this to prepare board or committee materials, record a decision that needs to be minuted, set or check approval authority, review insurance and continuity coverage, establish a retention policy, or work out where a responsibility belongs when it falls between functions.
日本語の概要は準備中です。原文の説明を表示しています。
cbrock84/headcount☆ 2,0662026年9月18日 更新
Covers what the organization owns and what it is only borrowing — trademarks and clearance, copyright and work-for-hire, patents and trade secrets, open-source license obligations and copyleft reach, and IP terms in customer, contractor and AI-tool agreements. Use this to check whether a name is usable, establish that you own work you paid for, decide how to handle a license obligation in a dependency, or respond to an infringement claim.
日本語の概要は準備中です。原文の説明を表示しています。
cbrock84/headcount☆ 2,0662026年9月18日 更新
Designs and tests controls over financial reporting — segregation of duties, approval limits, evidence, and preparing for audit. Use this to design controls for a process, prepare for an external audit, respond to an audit finding, set approval thresholds, or assess where a small team's segregation of duties is genuinely broken.
日本語の概要は準備中です。原文の説明を表示しています。
cbrock84/headcount☆ 2,0662026年9月18日 更新
Optimizes for AI assistants and AI-generated answers — being retrievable, being cited, and being represented accurately when a model answers on your behalf. Use this when traffic is shifting from links to AI answers, when a brand is misrepresented or absent in AI responses, when planning content for retrieval rather than ranking, or when deciding how AI search changes an existing SEO program.
日本語の概要は準備中です。原文の説明を表示しています。
cbrock84/headcount☆ 2,0662026年9月18日 更新
Pre-release gate — run the full gate, responsive + render checks, then produce the release checklist (README badge/current/changelog). Use before tagging a release.
日本語の概要は準備中です。原文の説明を表示しています。
plugin87/ux-ui-agent-skills☆ 2,0532026年10月11日 更新
Get current user profile summary to understand user's preferences and context. When you need to check known user info or personalize responses.
日本語の概要は準備中です。原文の説明を表示しています。
openakita/openakita☆ 2,0022026年9月24日 更新
Control deep thinking mode. Default enabled. For very simple tasks (simple reminders, greetings, quick queries), can temporarily disable to speed up response. Auto-restores to enabled after completion.
日本語の概要は準備中です。原文の説明を表示しています。
openakita/openakita☆ 2,0022026年9月24日 更新
Use this skill any time a spreadsheet file is the primary input or output. This means any task where the user wants to: open, read, edit, or fix an existing .xlsx, .xlsm, .csv, or .tsv file (e.g., adding columns, computing formulas, formatting, charting, cleaning messy data); create a new spreadsheet from scratch or from other data sources; or convert between tabular file formats. Trigger especially when the user references a spreadsheet file by name or path — even casually (like "the xlsx in my downloads") — and wants something done to it or produced from it. Also trigger for cleaning or restructuring messy tabular data files (malformed rows, misplaced headers, junk data) into proper spreadsheets. The deliverable must be a spreadsheet file. Do NOT trigger when the primary deliverable is a Word document, HTML report, standalone Python script, database pipeline, or Google Sheets API integration, even if tabular data is involved.
日本語の概要は準備中です。原文の説明を表示しています。
openakita/openakita☆ 2,0022026年9月24日 更新
Use when receiving code review feedback, before implementing suggestions, especially if feedback seems unclear or technically questionable - requires technical rigor and verification, not performative agreement or blind implementation
日本語の概要は準備中です。原文の説明を表示しています。
openakita/openakita☆ 2,0022026年9月24日 更新
Analyze images using Dashscope (Qwen) Vision models for detailed description, OCR text extraction, object recognition, and visual Q&A. Use when the user needs to understand image content via Alibaba Cloud Dashscope API, especially for Chinese-language image analysis and documents.
日本語の概要は準備中です。原文の説明を表示しています。
openakita/openakita☆ 2,0022026年9月24日 更新
Confirms what a third-party library, remote API, build backend, or scraped document actually does before writing code that depends on it — throwaway probes that run in seconds, permissive clients that forward wrong arguments instead of rejecting them, per-endpoint docs that don't generalize, response shapes that make a "fast path" always-false, fakes that encode your assumption rather than the service's behavior, and dry-runs that skip the step that fails. Use when integrating a new dependency or endpoint, writing a tolerated-status or error branch, choosing a client argument name, testing against a fake, or reviewing code that asserts an upstream contract.
日本語の概要は準備中です。原文の説明を表示しています。
kajisho5/ffmpeg-skill☆ 1,9852026年10月17日 更新
Unified Python access to 40+ bioinformatics web services; use when you need to query multiple databases (e.g., UniProt/KEGG/ChEMBL/Reactome) with one consistent API in a single workflow, especially for cross-database analysis and identifier mapping.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9692026年9月17日 更新
Write and revise the Methods section of research papers to ensure reproducibility; use when preparing an IMRAD manuscript or responding to journal/reporting-guideline requirements (e.g., CONSORT/STROBE/PRISMA).
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9692026年9月17日 更新
Predict challenging questions for presentations and prepare structured responses.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9692026年9月17日 更新
Transforms rough email drafts into polished, professional medical correspondence.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9692026年9月17日 更新
Generates a journal-ready cover letter from manuscript metadata, highlights, and journal-fit notes. Use when preparing an academic submission package and you need editor-facing language that clearly states novelty, relevance, declarations, and corresponding-author details.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9692026年9月17日 更新
Refines broad, vague, or aspirational biomedical research objectives into clear, bounded, measurable, executable, and downstream-ready study objective statements. Always use this skill when a user has a general aim such as “explore a mechanism,” “study prognosis,” “investigate biomarkers,” or “look at treatment response,” but the objective is still too broad, non-operational, or too ambiguous to support protocol framing, design selection, analysis planning, or hypothesis design. Never assume that polished wording alone means the objective is actionable. Focus first on objective type, missing operational elements, scope discipline, and downstream-ready formulation.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9692026年9月17日 更新
Designs a translational blueprint for moving a biomedical finding toward diagnosis, prognosis, treatment response prediction, patient stratification, or therapeutic development, with explicit translational milestones, validation thresholds, and feasibility-sensitive route framing.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9692026年9月17日 更新
Generates complete FAERS-style pharmacovigilance disproportionality research designs from a user-provided drug class, comparator strategy, adverse-event domain, and patient-group stratification. Always use this skill whenever a user wants to design, plan, or build a spontaneous-report safety signal study using FAERS or a similar pharmacovigilance database, especially when the article logic includes product selection, indication-group stratification, MedDRA-based adverse-event extraction, serious-case filtering, suspect-drug and concomitant-exclusion logic, reporting odds ratio analysis, comparator-drug benchmarking, cross-drug comparison, and cautious signal interpretation without causal overclaiming. Covers five study patterns (single-drug disproportionality workflow, multi-drug class comparison workflow, indication-stratified workflow, comparator-controlled signal screening workflow...
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9692026年9月17日 更新
Generates complete conventional single-gene oncology research designs from a user-provided cancer context, target gene, and validation direction. Use when a study centers on a fixed candidate gene and needs expression, prognosis, clinicopathologic association, functional interpretation, immune context, genomic or epigenetic context, optional drug-response hypotheses, and orthogonal validation. Covers five study patterns and always outputs Lite / Standard / Advanced / Publication+ with a recommended primary plan, stepwise workflow, figure plan, validation hierarchy, minimal executable version, publication upgrade path, and strictly verified literature retrieval.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9692026年9月17日 更新
Designs complete research plans that integrate clinical variables with multi-omics data from a user-provided biomedical direction. Always use this skill whenever a user wants to design, scope, or structure a study that combines clinical variables with transcriptomics, proteomics, metabolomics, epigenomics, or related omics layers for mechanism interpretation, biomarker development, risk stratification, treatment-response analysis, or translational use. It should define the clinical use case, alignment across data layers, feature-reduction and fusion logic, modeling route, mechanism-interpretation layer, validation ladder, and four workload configurations (Lite / Standard / Advanced / Publication+). Never fabricate datasets, accession numbers, sample counts, metadata completeness, platform coverage, literature references, PMIDs, DOIs, or validation status. Always include the mandatory Dataset Disclaimer immediately before any workflow section that mentions datasets or public resources.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9692026年9月17日 更新
Generates complete programmed-cell-death (PCD) / regulated-cell-death (RCD) bulk-transcriptome oncology research designs from a user-provided disease and mechanism theme. Always use this skill whenever a user wants to design, plan, or structure a cancer bioinformatics study built around cell-death patterns, tumor microenvironment, prognostic modeling, immune landscape analysis, mutation profiling, and computational drug sensitivity. Covers five study patterns (mechanism-gene-set, subtype-discovery, prognostic-signature, immune-response stratification, translational drug-hypothesis) and always outputs four workload configs (Lite / Standard / Advanced / Publication+) with recommended primary plan, step-by-step workflow, figure plan, validation strategy, minimal executable version, publication upgrade path, and a strictly verified reference literature retrieval layer with real references only.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9692026年9月17日 更新
Extracts concrete unmet clinical needs from guidelines, reviews, real-world studies, and clinical-practice evidence. Use this skill when a user wants to turn broad medical research value into specific clinical pain points such as weak early detection, poor risk stratification, treatment-response heterogeneity, monitoring gaps, diagnostic delay, undertreatment, overtreatment, or implementation failure. Always ground unmet-need claims in retrieved evidence and distinguish true care gaps from generic statements of importance.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9692026年9月17日 更新
Identifies translationally meaningful paths for bioinformatics findings by mapping omics or computational discoveries to diagnosis, stratification, prognosis, treatment-response, monitoring, or target-nomination use cases, while auditing bridge evidence, assayability, and validation burden. Use this skill when a user wants to know whether a bioinformatics finding can be framed as a stronger translational topic without overclaiming clinical relevance. Always separate statistical signal from translational value, and never imply clinical utility, targetability, or validation depth without explicit evidence support.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9692026年9月17日 更新